Skip to main content

Table 1 Baseline characteristics of the overall cohort and the cohort with expanded data collection

From: Impact of the COVID-19 pandemic on well-being and quality of life of patients with alpha-1-antitrypsin deficiency

Characteristics

Overall cohort

Expanded data collection

 

Mean ± SD (n)/ n (%)

Mean ± SD (n)/ n (%)

Sex (m)

192 (53.6%)

99 (53.5%)

Age (years)

63.72 ± 12.02 (355)

63.95 ± 10.52 (183)

BMI (kg/m2)

24.87 ± 5.23 (352)

24.55 ± 4.43 (177)

Non-smoker

110 (30.7)

73 (39.5)

Ever smoker

245 (68.4%)

123 (66.5%)

Pack-years

18.71 ± 14.17 (222)

16.87 ± 13.77 (111)

FEV1 (l)

2.01 ± 0.96 (307)

1.58 ± 0.82 (163)

FEV1 (%)

61.60 ± 26.58 (301)

55.22 ± 25.58 (151)

TLCO (mmol/min/kPa)

4.63 ± 3.12 (215)

4.35 ± 2.10 (71)

TLCO (%)

56.48 ± 25.28 (157)

47.20 ± 21.01 (54)

SGRQ total score

39.37 ± 20.04 (318)

45.15 ± 20.19 (159)

CAT score

 

17.28 ± 7.70 (167)